ampelopsin has been researched along with lead in 1 studies
Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (lead) | Trials (lead) | Recent Studies (post-2010) (lead) |
---|---|---|---|---|---|
377 | 2 | 343 | 37,002 | 214 | 14,398 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, C; Feng, ZJ; Jiang, H; Liu, CM; Ma, JQ; Sun, JM; Yang, HX; Yang, W | 1 |
1 other study(ies) available for ampelopsin and lead
Article | Year |
---|---|
Dihydromyricetin Inhibits Lead-Induced Cognitive Impairments and Inflammation by the Adenosine 5'-Monophosphate-Activated Protein Kinase Pathway in Mice.
Topics: AMP-Activated Protein Kinase Kinases; Ampelopsis; Animals; Apoptosis; Brain; Cognitive Dysfunction; Cytokines; Flavonols; Humans; Inflammation; Lead; Mice; NF-kappa B; Phosphorylation; Plant Extracts; Protein Kinases; Toll-Like Receptor 4 | 2018 |